DECIPHERA PHARMACEUTICALS IN filings

SEC filings by DECIPHERA PHARMACEUTICALS IN (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2024-02-14Redmile Group, LLCDeciphera Pharmaceuticals, Inc.8,359,7689.9%EDGAR
SC 13G/A2024-02-14BRAIDWELL LPDeciphera Pharmaceuticals, Inc.2,385,6232.9%EDGAR
SC 13G/A2024-02-14ARMISTICE CAPITAL, LLCDeciphera Pharmaceuticals, Inc.5,200,0006.5%EDGAR
SC 13G/A2024-02-13VANGUARD GROUP INCDeciphera Pharmaceuticals, Inc.4,401,6365.5%EDGAR
SC 13G/A2024-02-12Flynn James EDeciphera Pharmaceuticals, Inc.5,788,0247.2%EDGAR
SC 13G/A2024-02-09Brightstar Associates LLCDeciphera Pharmaceuticals, Inc.23,059,70828.2%EDGAR
SC 13G/A2024-02-06GOLDMAN SACHS GROUP INCDeciphera Pharmaceuticals, Inc.2,007,4472.5%EDGAR
SC 13G/A2024-01-26BlackRock Inc.Deciphera Pharmaceuticals, Inc.5,976,2667.5%EDGAR
SC 13G/A2024-01-23STATE STREET CORPDeciphera Pharmaceuticals, Inc.-3.1%EDGAR
SC 13G2023-03-22Flynn James EDeciphera Pharmaceuticals, Inc.4,627,3106.1%EDGAR
SC 13G/A2023-02-14BANK OF AMERICA CORP /DE/Deciphera Pharmaceuticals, Inc.302,4100.4%EDGAR
SC 13G/A2023-02-14Redmile Group, LLCDeciphera Pharmaceuticals, Inc.7,108,0979.9%EDGAR
SC 13G/A2023-02-14ARMISTICE CAPITAL, LLCDeciphera Pharmaceuticals, Inc.5,172,0007.6%EDGAR
SC 13G2023-02-14BRAIDWELL LPDeciphera Pharmaceuticals, Inc.4,599,4846.7%EDGAR
SC 13G/A2023-02-10Flynn James EDeciphera Pharmaceuticals, Inc.2,349,2283.5%EDGAR
SC 13G/A2023-02-09VANGUARD GROUP INCDeciphera Pharmaceuticals, Inc.4,745,3217.0%EDGAR
SC 13G/A2023-02-08GOLDMAN SACHS GROUP INCDeciphera Pharmaceuticals, Inc.3,836,1595.7%EDGAR
SC 13G/A2023-02-08Brightstar Associates LLCDeciphera Pharmaceuticals, Inc.23,107,84428.2%EDGAR
SC 13G/A2023-02-03STATE STREET CORPDeciphera Pharmaceuticals, Inc.-5.1%EDGAR
SC 13G/A2023-02-03BlackRock Inc.Deciphera Pharmaceuticals, Inc.5,420,0258.0%EDGAR